CMFRI, Library (2022) CMFRI develops seaweed-based product to fight non-alcoholic fatty liver The Hindu dated 21st December 2022. The HIndu.
![[img]](http://eprints.cmfri.org.in/style/images/fileicons/text.png) |
Text
The Hindu_ 21-12-2022.pdf Download (164kB) |
Official URL: https://www.thehindu.com/news/cities/Kochi/cmfri-d...
Abstract
The CMFRI signed a memorandum of understanding (MoU) with Emineotech, a private limited company dealing with health products, for commercial production and marketing of patent-protected Nutraceutical developed by the ICAR-Central Marine Fisheries Research Institute (CMFRI) from seaweeds to combat non-alcoholic fatty liver disease (NAFLD). Dr.Gopalakrishnan, Director of CMFRI signed a licence agreement with Evanjalist Pathrose, managing director of Emineotech.
| Item Type: | Article |
|---|---|
| Subjects: | CMFRI News Clippings |
| Divisions: | CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 26 Dec 2022 04:41 |
| Last Modified: | 26 Dec 2022 04:41 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16547 |
Actions (login required)
 |
View Item |
